Position in BLLN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,036,660
New position
Shares Held
16,975
first reported quarter
Ownership
0.036%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#71
of 156 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026POLEN CAPITAL MANAGEMENT LLC holds $293,593,664 across 6 Diagnostics & Research names. BLLN ranks #4 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
532,384 | $280,268,232 | |
| 2 | TWST |
Twist Bioscience Corp
|
55,310 | $5,690,292 | |
| 3 | GH |
Guardant Health, Inc.
|
34,372 | $5,156,831 | |
| 4 | BLLN |
BillionToOne, Inc.
This page
|
16,975 | $2,036,660 | |
| 5 | NTRA |
Natera, Inc.
|
1,627 | $441,649 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
25,614 | $0 |
All Filings in BLLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,036,660 | 16,975 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||